President Donald Trump has announced plans to build a new class of heavily armed amphibious naval battleships named after himself, as part of a new "golden fleet" of advanced warships. "As commander in chief, it's my great honor to announce that I have approved a plan for the Navy to begin the construction of two brand-new, very large — largest we've ever built — battleships," Trump announced fro
Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications. Aptamer grants Alphazyme a non-exclusive licence for use of an enzyme-modulating Optimer in hot-start PCR and next-generation...
The Justice Department has sued the District of Columbia, alleging that the District government and its Metropolitan Police Department unconstitutionally banned semi-automatic firearms. The District of Columbia's gun laws require anyone seeking to own a gun to register it with D.C. Metro Police. However, the D.C. Code provides a broad registration ban on numerous firearms, including the AR-15 and
ITOCHU (IOC.F) has signed an import and distribution agreement for the Japanese market with Vinarchy, an Australian winery. Beginning in January 2026, ITOCHU will be responsible for importing Vinarchy products, while ITOCHU-Shokuhin Co. will handle sales, beginning the domestic distribution of Vinarchy's...
Vantiva S.A. (VANTI.PA), on Tuesday announced that its Board of Directors has elected Katleen Vandeweyer as Chairwoman of the Board. Vandeweyer, who previously served as Lead Independent Director, will take over from Brian Shearer, who has stepped down from the Board following the transition. The...
Santen Pharmaceutical Co., Ltd. (SNPHY, 4536.T) announced the launch of Verkazia (Ciclosporin Eye Drops III) in China for the treatment of severe vernal keratoconjunctivitis (VKC) in children and young adults. With this introduction, Santen aims to provide a new therapeutic option for patients aged four...
Viridian Therapeutics Inc. (VRDN) announced that the FDA has accepted its Biologics License Application for Veligrotug, proposed for the treatment of thyroid eye disease, for priority review, with a decision expected by June 30, 2026. The application was supported by positive data from THRIVE and...
BUMA Australia Pty Ltd , a wholly owned subsidiary of PT Bukit Makmur Mandiri Utama under Indonesian-listed holding company PT BUMA Internasional Grup Tbk, announced that the Supreme Court of Queensland has delivered its judgment in the case of BUMA Australia Pty Ltd v Queensland Power Company Pty Ltd...
Sanofi (SNY, SAN.PA) said The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent or dupilumab for the treatment of bronchial asthma in children aged 6 to 11 years with severe or refractory disease whose symptoms are inadequately controlled...
Novo Nordisk B A/S (NVO, NOVOB.CO), a Denmark-based healthcare major, announced that the FDA has approved Wegovy pill, a once-daily 25 mg oral semaglutide, to reduce excess body weight, maintain long-term weight reduction, and reduce the risk of major adverse cardiovascular events. Following the...
Tokyo Century Corporation announced that it has signed an agreement with asset management funds under Octopus Energy Generation, part of the global energy company Octopus Energy Group, to co-invest in operating solar and onshore wind power plants. This strategic partnership will enable Tokyo Century...
ZIM Integrated Shipping Services Ltd.(ZIM) said that it has received competitive proposals from multiple parties to acquire all ZIM shares. The company is currently evaluating such proposals as part of its review of strategic alternatives. "The strategic review, which is in advanced stages, includes...
Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa (denosumab-mobz), a biosimilar referencing Prolia, and Oziltus (denosumab-mobz), a biosimilar referencing XGEVA. The company added...
RxSight, Inc. (RXST), an ophthalmic medical device company, on Tuesday announced that Chief Financial Officer Shelley Thunen is transitioning from her role. Thunen will remain with the company until the earlier of the appointment of a replacement or January 31, 2026. Thunen has agreed to continue...
Huntington Bancshares Inc. (HBAN, HBANP), on Tuesday announced that the Office of the Comptroller of the Currency has approved the proposed merger of Cadence Bank (CADE) with and into The Huntington National Bank, which will remain as the surviving bank. The terms of the transaction have not been...
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.